Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reducing painful colonoscopies in women in a Norwegian colorectal cancer screening program
2016-005090-13Phase 4Completed
- Sponsor
- Cancer Registry of Norway
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fentanyl and alfentanil (3 arms), sponsored by Cancer Registry of Norway. Primary endpoints: Pain score on 4-point Likert scale, Pain score on 100 mm visual analogue scale at splenic flexure and 2 more. Started Jan 2017; status: completed.
02
Drugs
fentanylalfentanil
Beyond the preview
Go deeper on 2016-005090-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005090-13.